Live news related to HYLORIS stock (BE0974363955): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on HYLORIS mainly cover M&A activity. The stock trades at €3,83 on Euronext Paris, down 0,78% at the last update. This page lists the articles published on HYLORIS stock to track the share price, company announcements and any item likely to influence market perception.
The Belgian pharmaceutical group announced in the evening, in a regulated information press release, the establishment of a €5M renewable credit line …
The Belgian laboratory saw its listing suspended this morning during a visit by authorities to its headquarters. The share rebounds sharply higher in …
The Belgian pharmaceutical laboratory, listed on Euronext Brussels, indicated that this action concerns access to certain documents related to histori…
Belgian pharmaceutical company Hyloris Pharmaceuticals has announced that its partner AFT Pharmaceuticals has concluded an exclusive agreement with Ja…
